How long is a course of treatment with giritinib? How to take it?

Giritinib, as a protein kinase inhibitor specifically targeting acute myeloid leukemia (AML) caused byFLT3 gene mutations, has demonstrated its excellent therapeutic effect in clinical practice. However, for many patients, questions remain about the length of treatment and how to take gilitinib. This article will answer these questions in detail to help patients better understand and use this drug.

First of all, regarding the duration of giritinib treatment, this usually depends on the patient's specific condition, treatment response, and doctor's recommendations. Generally speaking, the treatment of AML is a long-term and complex process, and giritinib often needs to be used as part of comprehensive treatment in combination with other drugs or treatments. Therefore, patients need to determine the length of treatment with gilitinib according to their personal treatment plan and response under the guidance of their doctor. It should be noted that response to giritinib may be delayed. Therefore, in the absence of disease progression or unacceptable toxicity, patients should receive treatment for at least 6 months to allow time for clinical response.

When taking giritinib, patients should strictly follow the doctor's instructions and prescriptions. Giritinib is usually administered orally at a starting dose of 120 mg once daily, and the dose may be adjusted based on patient response. While patients are taking giritinib, they should have regular blood tests and physical examinations so that doctors can understand the treatment effects in a timely manner and adjust the drug dosage or treatment plan as needed. It should be noted that giritinib may have some side effects, such as nausea, vomiting, diarrhea, etc. If patients experience any discomfort or abnormal reactions while taking the medicine, they should promptly inform their doctor so that they can receive timely treatment and adjustment. In addition, patients should also pay attention to maintaining good living and dietary habits while taking giritinib to enhance the body's resistance and improve the treatment effect. At the same time, avoid using it at the same time with other drugs to avoid drug interactions and affect the therapeutic effect.

According to inquiries, giritinib is currently approved for marketing in China, but its price is expensive and difficult for patients to afford. There are some affordable generic drugs available overseas, and patients can choose according to their needs.